These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26545586)

  • 1. Identification and characterization of a new type of inhibitor against the human immunodeficiency virus type-1 nucleocapsid protein.
    Kim MJ; Kim SH; Park JA; Yu KL; Jang SI; Kim BS; Lee ES; You JC
    Retrovirology; 2015 Nov; 12():90. PubMed ID: 26545586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
    Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
    Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleocapsid Annealing-Mediated Electrophoresis (NAME) assay allows the rapid identification of HIV-1 nucleocapsid inhibitors.
    Sosic A; Cappellini M; Scalabrin M; Gatto B
    J Vis Exp; 2015 Jan; (95):52474. PubMed ID: 25650789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA.
    Moscardini M; Pistello M; Bendinelli M; Ficheux D; Miller JT; Gabus C; Le Grice SF; Surewicz WK; Darlix JL
    J Mol Biol; 2002 Apr; 318(1):149-59. PubMed ID: 12054775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and structural characterization of a new inhibitor series of HIV-1 nucleocapsid function: NMR solution structure determination of a ternary complex involving a 2:1 inhibitor/NC stoichiometry.
    Goudreau N; Hucke O; Faucher AM; Grand-Maître C; Lepage O; Bonneau PR; Mason SW; Titolo S
    J Mol Biol; 2013 Jun; 425(11):1982-1998. PubMed ID: 23485336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic differences between HIV-1 and SIV nucleocapsid proteins and cross-species HIV-1 genomic RNA recognition.
    Post K; Olson ED; Naufer MN; Gorelick RJ; Rouzina I; Williams MC; Musier-Forsyth K; Levin JG
    Retrovirology; 2016 Dec; 13(1):89. PubMed ID: 28034301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.
    Mori M; Kovalenko L; Malancona S; Saladini F; De Forni D; Pires M; Humbert N; Real E; Botzanowski T; Cianférani S; Giannini A; Dasso Lang MC; Cugia G; Poddesu B; Lori F; Zazzi M; Harper S; Summa V; Mely Y; Botta M
    ACS Chem Biol; 2018 Jan; 13(1):253-266. PubMed ID: 29235845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The matrix domain contributes to the nucleic acid chaperone activity of HIV-2 Gag.
    Pachulska-Wieczorek K; Błaszczyk L; Biesiada M; Adamiak RW; Purzycka KJ
    Retrovirology; 2016 Mar; 13():18. PubMed ID: 26987314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and stabilization of the RNA aptamers against the human immunodeficiency virus type-1 nucleocapsid protein.
    Kim SJ; Kim MY; Lee JH; You JC; Jeong S
    Biochem Biophys Res Commun; 2002 Mar; 291(4):925-31. PubMed ID: 11866454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity.
    Mori M; Nucci A; Lang MC; Humbert N; Boudier C; Debaene F; Sanglier-Cianferani S; Catala M; Schult-Dietrich P; Dietrich U; Tisné C; Mely Y; Botta M
    ACS Chem Biol; 2014 Sep; 9(9):1950-5. PubMed ID: 24988251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tryptophan-rich hexapeptide inhibits nucleic acid destabilization chaperoned by the HIV-1 nucleocapsid protein.
    Raja C; Ferner J; Dietrich U; Avilov S; Ficheux D; Darlix JL; de Rocquigny H; Schwalbe H; Mély Y
    Biochemistry; 2006 Aug; 45(30):9254-65. PubMed ID: 16866372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fullerene Derivatives Prevent Packaging of Viral Genomic RNA into HIV-1 Particles by Binding Nucleocapsid Protein.
    Křížová I; Dostálková A; Castro E; Prchal J; Hadravová R; Kaufman F; Hrabal R; Ruml T; Llano M; Echegoyen L; Rumlová M
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HIV-1 inhibitors targeting the nucleocapsid protein.
    Breuer S; Chang MW; Yuan J; Torbett BE
    J Med Chem; 2012 Jun; 55(11):4968-77. PubMed ID: 22587465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of HIV-1 Nucleocapsid Protein Inhibition by Lysyl-Peptidyl-Anthraquinone Conjugates.
    Sosic A; Sinigaglia L; Cappellini M; Carli I; Parolin C; Zagotto G; Sabatino G; Rovero P; Fabris D; Gatto B
    Bioconjug Chem; 2016 Jan; 27(1):247-56. PubMed ID: 26666402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the interaction between the HIV-1 Gag structural polyprotein and the cellular ribosomal protein L7 and its implication in viral nucleic acid remodeling.
    Mekdad HE; Boutant E; Karnib H; Biedma ME; Sharma KK; Malytska I; Laumond G; Roy M; Réal E; Paillart JC; Moog C; Darlix JL; Mély Y; de Rocquigny H
    Retrovirology; 2016 Aug; 13(1):54. PubMed ID: 27515235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific interactions between HIV-1 nucleocapsid protein and the TAR element.
    Kanevsky I; Chaminade F; Ficheux D; Moumen A; Gorelick R; Negroni M; Darlix JL; Fossé P
    J Mol Biol; 2005 May; 348(5):1059-77. PubMed ID: 15854644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural determinants of HIV-1 nucleocapsid protein for cTAR DNA binding and destabilization, and correlation with inhibition of self-primed DNA synthesis.
    Beltz H; Clauss C; Piémont E; Ficheux D; Gorelick RJ; Roques B; Gabus C; Darlix JL; de Rocquigny H; Mély Y
    J Mol Biol; 2005 May; 348(5):1113-26. PubMed ID: 15854648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Mg(2+) and Na(+) on the nucleic acid chaperone activity of HIV-1 nucleocapsid protein: implications for reverse transcription.
    Vo MN; Barany G; Rouzina I; Musier-Forsyth K
    J Mol Biol; 2009 Feb; 386(3):773-88. PubMed ID: 19154740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity.
    Humbert N; Kovalenko L; Saladini F; Giannini A; Pires M; Botzanowski T; Cherenok S; Boudier C; Sharma KK; Real E; Zaporozhets OA; Cianférani S; Seguin-Devaux C; Poggialini F; Botta M; Zazzi M; Kalchenko VI; Mori M; Mély Y
    ACS Infect Dis; 2020 Apr; 6(4):687-702. PubMed ID: 32045204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid protein.
    Mori M; Schult-Dietrich P; Szafarowicz B; Humbert N; Debaene F; Sanglier-Cianferani S; Dietrich U; Mély Y; Botta M
    Virus Res; 2012 Nov; 169(2):377-87. PubMed ID: 22634301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.